FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

AbbVie Files NDA for Endometriosis Pain

[ Price : $8.95]

AbbVie files an NDA for elagolix, an investigational, orally administered gonadotropin-releasing hormone antagonist, indicated for...

FDA Praised for Supply Chain Enforcement Delay

[ Price : $8.95]

Stakeholders praise FDA for enforcement discretion for manufacturers to meet Drug Supply Chain Security Act product identifier req...

QLRAD Marketing Unapproved Medical Device: FDA

[ Price : $8.95]

FDA warns a Netherlands firm it is marketing a medical device in the U.S. without agency approval or clearance.

FDA Clinical Hold on Cell Therapy After Patient Dies

[ Price : $8.95]

FDA places a clinical hold on two Cellectis Phase 1 studies involving cell therapy UCART123 in acute myeloid leukemia and in blast...

Significant Violations at Steiner Clinical Study Site

[ Price : $8.95]

FDA warns Steiner Biotechnology about violations in its role as a sponsor-investigator of medical device clinical trials.

Medical Device Study Site Violations

[ Price : $8.95]

FDA warns Entellus Medical about violations in its work as sponsor of a medical device clinical study.

Ban UHDU Opioid Analgesics: Groups

[ Price : $8.95]

Six health groups ask FDA to remove ultra-high dosage unit opioid analgesics from the market because their harms outweigh the bene...

Interoperable Medical Device Design Guidance

[ Price : $8.95]

FDA publishes a guidance listing items to consider when developing and designing interoperable medical devices.

Draft Guide on REMS eSubmissions

[ Price : $8.95]

Federal Register notice: FDA makes available a draft guidance on Providing Regulatory Submissions in Electronic Format Content of...

Insmed Seeking Accelerated Approval for Lung Disease Drug

[ Price : $8.95]

Insmed plans to seek accelerated approval of its inhaled therapy Alis (amikacin) based on data from the CONVERT study in adult pat...